Learn more KPV Peptide Therapy KPV is a three-amino-acid peptide derived from the body's own anti-inflammatory hormone, studied to ease chronic inflammation in the gut, skin, and joints without broad immune suppression
If you notice a site consistently causes more irritation than others, mention it at your next check-in, since some patients have body composition factors that make certain sites less ideal for them
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
These landmark studies established that GLP-1 medications deliver clinically significant results in non-diabetic populations, leading to FDA recognition of semaglutide and tirzepatide as weight loss agents independent of diabetes status
It enhances sleep, cognitive performance, skin health, and possibly prevents tumor growth
Discussion Aside from the top 10% of responders in our real-world study, we found that GLP-1s resulted in smaller reductions in both weight loss and HbA1c, respectively